The incidence and mortality rate of Breast Cancer (BC) are global problems for women, with
over 2.1 million new diagnoses each year worldwide. There is no age range, race, or …

Imaging is paramount for the early detection and clinical staging of breast cancer, as well as
to inform management decisions and direct therapy. PET–MRI is a quantitative hybrid …

Background Integrated PET/MRI is a promising modality for breast assessment. The most
frequently used tracer, fluorine 18 (18F) fluorodeoxyglucose (FDG), is applied for whole …

Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer
worldwide, with an estimated 2.3 million new cases (11.7%), followed by lung cancer …

Estrogen receptor (ER) is highly expressed in 70%-80% of breast cancers and plays a
central role in prognosis and treatment selection for patients with breast cancer. The gold …

Background Breast cancer is the most frequent cancer in women and remains the second
leading cause of death in Western countries. It represents a heterogeneous group of …

Breast cancer is the most common cancer among women in the United States and the
second leading cause of cancer-related deaths; approximately 12.9% of women will be …

Introduction: Our aim was to evaluate the performance in clinical research and in clinical
routine of a research prototype, called positron emission tomography (PET) Assisted …

Simple Summary Artificial intelligence (AI) has seamlessly integrated into the medical field,
especially in diagnostic imaging, thanks to ongoing AI advancements. It is widely used in …